| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.099 | 0.02 |